Intralesional Versus Intramuscular Hepatitis B Vaccine Immunotherapy for Warts

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 25, 2020

Primary Completion Date

June 20, 2021

Study Completion Date

October 25, 2021

Conditions

Intralesional Versus Intramuscular Hepatitis B Vaccine for Multiple Common Warts

Interventions

BIOLOGICAL

hepatitis B vaccine immunotherapy of common warts (GeneVac-B 10 ml vial, Serum Institute of India Ltd., Pune, India)

Randomized placebo-controlled comparative effectiveness clinical trial

BIOLOGICAL

Intralesional saline

Trial Locations (1)

Zagazig university, Zagazig

All Listed Sponsors

lead

Zagazig University

OTHER_GOV

NCT05326152 - Intralesional Versus Intramuscular Hepatitis B Vaccine Immunotherapy for Warts | Biotech Hunter | Biotech Hunter